Relationship between depression and inflammatory factors and brain-derived neurotrophic factor in patients with perimenopause syndrome

Guo,Li; Ren,Lidong; Zhang,Caixia

doi:10.3892/etm.2018.5985

Relationship between depression and inflammatory factors and brain-derived neurotrophic factor in patients with perimenopause syndrome

Authors:
- Li Guo
- Lidong Ren
- Caixia Zhang
View Affiliations

Affiliations: Department of Gynaecology and Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, P.R. China, Department of Breast, Thyroid, Hernia and Vascular Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia 010050, P.R. China
Published online on: March 22, 2018 https://doi.org/10.3892/etm.2018.5985
Pages: 4436-4440
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The relationship of depression with levels of serum inflammatory factors and brain-derived neurotrophic factor (BDNF) in patients with perimenopausal syndrome was analyzed to investigate the predictive values of risk factors for depression in patients with perimenopausal syndrome. A total of 73 patients with perimenopausal syndrome were selected, and divided into the depression (n=30) and non-depression (n=43) groups. Results showed that the self-rating anxiety scale (SAS) and self-rating depression scale (SDS) scores in the depression group were significantly higher than those in the non-depression group (P<0.05). The serum BDNF level in the depression group was significantly lower than that in the non-depression group (P<0.05). The levels of serum inflammatory factors, including C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), in depression group were obviously higher than those in non‑depression group (P<0.05). The correlation analyses of serum inflammatory factor and BDNF levels with depression showed that CRP and TNF-α were positively correlated with SDS score, while BDNF level was negatively correlated with SDS score. Logistic regression analyses revealed that menstrual status, chronic diseases, serum inflammatory factors (CRP, IL-6 and TNF-α) and BDNF levels had independent predictive values for depression in patients with perimenopausal syndrome (P<0.05). In conclusion, levels of serum CRP, IL-6, TNF-α and BDNF can be used as judgment indicators for the severity of depression.

View Figures

View References

1	Zhou B, Sun X, Zhang M, Deng Y and Hu J: The symptomatology of climacteric syndrome: Whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety-depression disorder. Arch Gynecol Obstet. 285:1345–1352. 2012. View Article : Google Scholar : PubMed/NCBI
2	Gibbs Z, Lee S and Kulkarni J: Factors associated with depression during the perimenopausal transition. Womens Health Issues. 23:e301–e307. 2013. View Article : Google Scholar : PubMed/NCBI
3	Graziottin A and Serafini A: Depression and the menopause: Why antidepressants are not enough? Menopause Int. 15:76–81. 2009. View Article : Google Scholar : PubMed/NCBI
4	Sun N, Yang CX, Liu ZF, Li XR, Xu Y and Zhang KR: Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population. Eur Rev Med Pharmacol Sci. 20:1852–1859. 2016.PubMed/NCBI
5	Studd JW: A guide to the treatment of depression in women by estrogens. Climacteric. 14:637–642. 2011. View Article : Google Scholar : PubMed/NCBI
6	Harte-Hargrove LC, Maclusky NJ and Scharfman HE: Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: Implications for normal brain function and disease. Neuroscience. 239:46–66. 2013. View Article : Google Scholar : PubMed/NCBI
7	Scharfman HE and MacLusky NJ: Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: Complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol. 27:415–435. 2006. View Article : Google Scholar : PubMed/NCBI
8	Aguirre CC and Baudry M: Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci. 29:447–454. 2009. View Article : Google Scholar : PubMed/NCBI
9	Strauss JR: The reciprocal relationship between menopausal symptoms and depressive symptoms: A 9-year longitudinal study of American women in midlife. Maturitas. 70:302–306. 2011. View Article : Google Scholar : PubMed/NCBI
10	Tuomisto H, Salo P, Saarinen R, Kalleinen N and Polo-Kantola P: The association of serum oestradiol level, age, and education with cognitive performance in peri- and late postmenopausal women. Maturitas. 71:173–179. 2012. View Article : Google Scholar : PubMed/NCBI
11	Song IU, Kim YD, Kim JS, Lee KS and Chung SW: Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke? Eur Neurol. 64:304–310. 2010. View Article : Google Scholar : PubMed/NCBI
12	Kroenke K, Spitzer RL and Williams JB: The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 16:606–613. 2001. View Article : Google Scholar : PubMed/NCBI
13	Wojnar M, Drózdz W, Araszkiewicz A, Szymański W, Nawacka-Pawlaczyk D and Urbański R: Prevalence of depressive disorders among perimenopausal women seeking gynecological services. Psychiatr Pol. 37:811–824. 2003.(In Polish). PubMed/NCBI
14	Huerta R, Mena A, Malacara JM and de León JD: Symptoms at the menopausal and premenopausal years: Their relationship with insulin, glucose, cortisol, FSH, prolactin, obesity and attitudes towards sexuality. Psychoneuroendocrinology. 20:851–864. 1995. View Article : Google Scholar : PubMed/NCBI
15	Komesaroff PA, Esler MD and Sudhir K: Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 84:606–610. 1999. View Article : Google Scholar : PubMed/NCBI
16	Miklowitz DJ: Delinquency, depression, and psychosis among adolescents in foster care: What holds three heads together? J Am Acad Child Adolesc Psychiatry. 53:1251–1253. 2014. View Article : Google Scholar : PubMed/NCBI
17	Reinhardt JP, Horowitz A, Cimarolli VR, Eimicke JP and Teresi JA: Addressing depression in a long-term care setting: A phase II pilot of problem-solving treatment. Clin Ther. 36:1531–1537. 2014. View Article : Google Scholar : PubMed/NCBI
18	Kwasky AN and Groh CJ: Vitamin D, depression and coping self-efficacy in young women: Longitudinal study. Arch Psychiatr Nurs. 28:362–367. 2014. View Article : Google Scholar : PubMed/NCBI
19	Rosario JL, Bezerra Diógenes MS, Mattei R and Leite JR: Differences and similarities in postural alterations caused by sadness and depression. J Bodyw Mov Ther. 18:540–544. 2014. View Article : Google Scholar : PubMed/NCBI
20	Hayden EP, Olino TM, Mackrell SV, Jordan PL, Desjardins J and Katsiroumbas P: Cognitive vulnerability to depression during middle childhood: Stability and associations with maternal affective styles and parental depression. Pers Individ Dif. 55:892–897. 2013. View Article : Google Scholar : PubMed/NCBI